PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17372243-7	2007	The most common CYP1B1 haplotype was Arg(48)-Ala(119)-Val(432)-Asn(453).	Arginine	37-40	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	16-22	
18573508-1	2008	In the present study, genotype and haplotype frequencies of four polymorphisms of cytochrome P450 1B1 (CYP1B1) that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at 432 and Asn-Ser at codon 453) were studied in 200 patients suffering from lung cancer and equal number of controls.	Arginine	142-145	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	82-101	
18573508-1	2008	In the present study, genotype and haplotype frequencies of four polymorphisms of cytochrome P450 1B1 (CYP1B1) that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at 432 and Asn-Ser at codon 453) were studied in 200 patients suffering from lung cancer and equal number of controls.	Arginine	142-145	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	103-109	
18067928-2	2008	In the present study, genotype and haplotype frequencies of four single nucleotide polymorphisms (SNPs) in CYP1B1 that cause amino acid changes (Arg-Gly at codon 48, Ala-Ser at codon 119, Leu-Val at codon 432 and Asn-Ser at codon 453) were studied in 150 cases suffering from head and neck squamous cell carcinoma (HNSCC) and in an equal number of controls.	Arginine	145-148	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	107-113	
15734954-5	2005	The common alleles of the CYP1B1 gene were Arg (79.97%) in codon 48, Ala (80.53%) in codon 119, and Leu (86.57%) in codon 432.	Arginine	43-46	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	26-32	
16569655-10	2006	The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer.	Arginine	197-200	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	138-144	
16569655-10	2006	The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer.	Arginine	201-204	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	138-144	
16569655-10	2006	The decreased risk we observed with the hOGG1 326 Cys/Cys genotype confirms an earlier report and the further reduced risk found with the CYP1B1 (432 Leu/Leu or Leu/Val)-hOGG1 (326 Cys/Cys)-XRCC1 (Arg/Arg or Arg/Gln) genotype combination may lend new insights to the importance of ROS generated from non-receptor-mediated estrogenic mechanisms in more aggressive prostate cancer.	Arginine	201-204	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	138-144	
15176218-5	2004	In the same patients, receptor-negative tumors occurred more often (p = 0.032) than in combinations of higher level of 4-hydroxylase estradiol of S-allele in position 48 (Gly/Arg) of the CYP1B1 gene.	Arginine	175-178	cytochrome P450 family 1 subfamily B member 1	Homo sapiens	187-193